HIV Treatment as Prevention: Modelling the Cost of Antiretroviral Treatment—State of the Art and Future Directions

  • Gesine Meyer-Rath mail,

    Affiliations: Center for Global Health and Development, Boston University, Boston, Massachusetts, United States of America, Health Economics and Epidemiology Research Office, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa

  • Mead Over

    Affiliation: Center for Global Development, Washington, District of Columbia, United States of America

  • Published: July 10, 2012
  • DOI: 10.1371/journal.pmed.1001247
  • Published in PLOS Medicine

Media Coverage of this Article

Found additional news media or blog coverage for the article? Please let us know.

Linked Articles

HIV Treatment as Prevention: Issues in Economic Evaluation

Till Bärnighausen, Joshua A. Salomon, Nalinee Sangrujee
Review | published 10 Jul 2012 | PLOS Medicine